Thompson Peter A.

Average Profitability
<0.0001%
Insider Buys Quantity
29
Insider Buys Sum
$129.75M
Insider Sells Quantity
11
Insider Sells Sum
$46.86M

Insider Activity of Thompson Peter A.

According to the SEC Form 4 filings, Thompson Peter A., being in a position of

  1. at Edgewise Therapeutics, Inc.,
    оver the last 12 months, has bought 454545 shares for $5M, and sold 0 shares,
    over all time since 2021-03-30, has bought 1933791 share for $23.49M, and sold 0 shares.

The largest purchase of all time was on 2016-05-23 and amounted to 2383200 shares of Adaptimmune Therapeutics plc for $24.79M.

The largest sale of all time was on 2018-03-27 and amounted to 2032168 shares of Adaptimmune Therapeutics plc for $23.37M.

Biography of Thompson Peter A.

No biography is available at this moment.

2024-01-23PurchaseEdgewise Therapeutics, Inc.
EWTX
454,545
0.5075%
$11.00$5M+13.41%
2022-09-16PurchaseEdgewise Therapeutics, Inc.
EWTX
484,496
1.0067%
$10.32$5M-6.89%
2022-05-18PurchaseEdgewise Therapeutics, Inc.
EWTX
276,000
0.5524%
$7.21$1.99M+30.03%
2021-12-29SaleJanux Therapeutics, Inc.
JANX
director
40,400
0.1004%
$20.30$820,120-30.21%
2021-12-21SaleJanux Therapeutics, Inc.
JANX
director
119,400
0.2901%
$19.00$2.27M-26.45%
2021-12-16SaleJanux Therapeutics, Inc.
JANX
director
393,300
0.9489%
$19.07$7.5M-26.9%
2021-09-20SaleCorvus Pharmaceuticals, Inc.
CRVS
1.11M
2.4922%
$6.09$6.76M-73.58%
2021-06-15PurchaseJanux Therapeutics, Inc.
JANX
director
705,853
6.4368%
$17.00$12M+1.61%
2021-03-30PurchaseEdgewise Therapeutics, Inc.
EWTX
718,750
0.7478%
$16.00$11.5M-42.5%
2021-02-17PurchaseCorvus Pharmaceuticals, Inc.
CRVS
1.29M
3.6216%
$3.50$4.5M-23.75%
2020-09-25PurchasePMV Pharmaceuticals, Inc.
PMVP
950,000
7.5696%
$18.00$17.1M-7.38%
2019-08-06PurchaseCorvus Pharmaceuticals, Inc.
CRVS
142,656
0.4786%
$3.51$500,723-1.4%
2019-07-01PurchaseCorvus Pharmaceuticals, Inc.
CRVS
59,243
0.1899%
$3.91$231,640-15.42%
2019-06-28PurchaseCorvus Pharmaceuticals, Inc.
CRVS
565,178
1.918%
$3.72$2.1M-5.88%
2019-06-27PurchaseCorvus Pharmaceuticals, Inc.
CRVS
32,923
0.1107%
$3.34$109,963+3.98%
2018-06-06SaleAdaptimmune Therapeutics plc
ADAP
director
3,200
0.0036%
$13.49$43,168-55.42%
2018-06-04SaleAdaptimmune Therapeutics plc
ADAP
director
34,200
0.0382%
$13.57$464,094-55.39%
2018-06-01SaleAdaptimmune Therapeutics plc
ADAP
director
100,000
0.1066%
$13.49$1.35M-57.22%
2018-05-30SaleAdaptimmune Therapeutics plc
ADAP
director
242,000
0.2641%
$13.52$3.27M-55.89%
2018-05-14SaleAdaptimmune Therapeutics plc
ADAP
director
20,600
0.0231%
$13.50$278,100-51.61%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.